NASDAQ: INBXV - Inhibrx, Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Нефтегаз

Share chart Inhibrx, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Inhibrx, Inc.

Inhibrx, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidate includes INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency.

more details
It also develops INBRX-109, a tetravalent therapeutic candidate targeting death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, colorectal cancer, ewing sarcoma, and pancreatic adenocarcinoma; and INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company has license and collaboration agreements with 2seventy bio, Inc. and Bristol-Myers Squibb Company. Inhibrx, Inc. was incorporated in 2009 and is headquartered in La Jolla, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2024-05-28
Валюта usd
Сайт https://inhibrx.com
Цена ао 30.85
Change price per day: 0% (30.85)
Change price per week: 0% (30.85)
Change price per month: 0% (30.85)
Change price per 3 month: 0% (30.85)
Change price per half year: 0% (30.85)
Change price per year to date: 0% (30.85)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 0 0
Yield EPS, % 0 0
Total: 0
More



Head Job title Payment Year of birth
Mr. Mark Paul Lappe Founder, Chairman, President & CEO 1967 (58 years)
Dr. Brendan P. Eckelman Ph.D. Founder & Chief Scientific Officer 1979 (46 years)
Mr. Quinn L. Deveraux Founder
Dr. Ashraf Amanullah Executive VP & Chief Technical Operations Officer 1968 (57 years)
Ms. Leah Pollema J.D. VP, Corporate Secretary & General Counsel
Dr. Charbel Helaihel Pharm.D. Vice President of Marketing & Commercial Planning
Mr. Jeffrey J. Jensen Executive VP & Chief Clinical Operations Officer
Mr. David Matly M.B.A. Executive VP and Chief Commercial & Business Development Officer
Dr. Carlos Bais Ph.D. Executive Vice President of Translational Sciences
Dr. Josep Garcia Ph.D. EVP & Chief Clinical Development Officer

Address: United States, La Jolla, 11025 North Torrey Pines Road - open in Google maps, open in Yandex maps
Website: https://inhibrx.com